TY - JOUR
T1 - Cardiovascular positron emission tomography
T2 - A possible tool for assessment of new pharmaceuticals
AU - Schwaiger, M.
AU - Kosa, I.
PY - 1997
Y1 - 1997
N2 - Positron emission tomography (PET) represents the most advanced scintigraphic imaging technology. This technology is being employed for cardiovascular research as well as for clinical applications in patients with various cardiovascular diseases. Together with a considerable number of radiopharmaceuticals, PET allows the noninvasive assessment of myocardial perfusion, myocardial substrate metabolism, and cardiac innervation. This article will briefly review the various aspects of scintigraphic tissue characterization provided by this technology in the heart.
AB - Positron emission tomography (PET) represents the most advanced scintigraphic imaging technology. This technology is being employed for cardiovascular research as well as for clinical applications in patients with various cardiovascular diseases. Together with a considerable number of radiopharmaceuticals, PET allows the noninvasive assessment of myocardial perfusion, myocardial substrate metabolism, and cardiac innervation. This article will briefly review the various aspects of scintigraphic tissue characterization provided by this technology in the heart.
KW - Cardiovascular research
KW - Positron emission tomography
UR - http://www.scopus.com/inward/record.url?scp=0030799582&partnerID=8YFLogxK
U2 - 10.1177/009286159703100347
DO - 10.1177/009286159703100347
M3 - Article
AN - SCOPUS:0030799582
SN - 0092-8615
VL - 31
SP - 1029
EP - 1034
JO - Drug Information Journal
JF - Drug Information Journal
IS - 3
ER -
